These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35837302)

  • 1. An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.
    Corsini S; Pedrini E; Patavino C; Gnoli M; Lanza M; Sangiorgi L
    Front Endocrinol (Lausanne); 2022; 13():874126. PubMed ID: 35837302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
    Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
    BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
    Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
    Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.
    Onsongo G; Baughn LB; Bower M; Henzler C; Schomaker M; Silverstein KA; Thyagarajan B
    J Mol Diagn; 2016 Nov; 18(6):872-881. PubMed ID: 27597741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
    Fowler A; Mahamdallie S; Ruark E; Seal S; Ramsay E; Clarke M; Uddin I; Wylie H; Strydom A; Lunter G; Rahman N
    Wellcome Open Res; 2016 Nov; 1():20. PubMed ID: 28459104
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations.
    Vink GR; White SJ; Gabelic S; Hogendoorn PC; Breuning MH; Bakker E
    Eur J Hum Genet; 2005 Apr; 13(4):470-4. PubMed ID: 15586175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families.
    Jennes I; de Jong D; Mees K; Hogendoorn PC; Szuhai K; Wuyts W
    BMC Med Genet; 2011 Jun; 12():85. PubMed ID: 21703028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer.
    Agaoglu NB; Unal B; Akgun Dogan O; Zolfagharian P; Sharifli P; Karakurt A; Can Senay B; Kizilboga T; Yildiz J; Dinler Doganay G; Doganay L
    Expert Rev Mol Diagn; 2022 Feb; 22(2):239-246. PubMed ID: 35240897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
    Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
    J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Pathogenic Large Duplication in EXT1 Identified in a Family with Multiple Osteochondromas.
    Bartolotti I; Sobul K; Corsini S; Scognamiglio D; Moroni A; Gnoli M; Sangiorgi L; Pedrini E
    Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical analysis of germline copy number variation in DMD using a non-conjugate hierarchical Bayesian model.
    Kozareva V; Stroff C; Silver M; Freidin JF; Delaney NF
    BMC Med Genomics; 2018 Oct; 11(1):91. PubMed ID: 30342520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of exon-level copy number variants in CytoScan XON assay and next-generation sequencing in clinical samples.
    Won D; Yeom E; Shin S; Lee ST; Rak Choi J
    Clin Chim Acta; 2024 Jun; 560():119703. PubMed ID: 38763467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic analysis of five pedigrees affected with multiple osteochondromas].
    Bai Y; Jiao Z; Liu N; Hu S; Zhao K; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jul; 37(7):717-720. PubMed ID: 32619249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of CNVs in NGS Data Using VS-CNV.
    Fortier N; Rudy G; Scherer A
    Methods Mol Biol; 2018; 1833():115-127. PubMed ID: 30039368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mutations in EXT1 and EXT2 in Brazilian patients with multiple osteochondromas.
    Santos SCL; Rizzo IMPO; Takata RI; Speck-Martins CE; Brum JM; Sollaci C
    Mol Genet Genomic Med; 2018 May; 6(3):382-392. PubMed ID: 29529714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PattRec: An easy-to-use CNV detection tool optimized for targeted NGS assays with diagnostic purposes.
    Roca I; González-Castro L; Maynou J; Palacios L; Fernández H; Couce ML; Fernández-Marmiesse A
    Genomics; 2020 Mar; 112(2):1245-1256. PubMed ID: 31349009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atlas-CNV: a validated approach to call single-exon CNVs in the eMERGESeq gene panel.
    Chiang T; Liu X; Wu TJ; Hu J; Sedlazeck FJ; White S; Schaid D; Andrade M; Jarvik GP; Crosslin D; Stanaway I; Carrell DS; Connolly JJ; Hakonarson H; Groopman EE; Gharavi AG; Fedotov A; Bi W; Leduc MS; Murdock DR; Jiang Y; Meng L; Eng CM; Wen S; Yang Y; Muzny DM; Boerwinkle E; Salerno W; Venner E; Gibbs RA
    Genet Med; 2019 Sep; 21(9):2135-2144. PubMed ID: 30890783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.